Skip to main content
PRFX
NASDAQ Life Sciences

PRF-110 Matches Approved Benchmark, Shows Favorable PK in Expanded Preclinical Study

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$1.49
Mkt Cap
$1.225M
52W Low
$1.28
52W High
$17.95
52W Position info
16% above low
Off High info
92% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

PRFX sits 16% above its 52-week low of $1.28 on light trading volume (0.1× avg).

Summary

PRF Technologies announced expanded preclinical results for its lead candidate, PRF-110, demonstrating analgesic efficacy comparable to the approved benchmark ZYNRELEF. The study also revealed a favorable pharmacokinetic profile for PRF-110, characterized by slower absorption and enhanced local tissue retention. This update follows initial positive preclinical results reported on May 26th, providing more detailed comparative data. For this clinical-stage micro-cap, these findings further validate PRF-110's potential as a differentiated, long-acting post-operative pain solution.

At the time of this announcement, PRFX was trading at $1.49 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.2M. The 52-week trading range was $1.28 to $17.95. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

PRFX - Latest Insights

PRFX
Nov 05, 2026, 4:15 PM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.7588
Real-time Price: $0.780 info
Change: +$0.0212 (+3%) info
Market Cap: $2.649M info
PRFX
Nov 03, 2026, 4:30 PM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.7705
Real-time Price: $0.780 info
Change: +$0.0095 (+1%) info
Market Cap: $2.649M info
PRFX
Nov 03, 2026, 4:01 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $0.711
Real-time Price: $0.780 info
Change: +$0.069 (+10%) info
Market Cap: $2.649M info
PRFX
Sep 24, 2026, 4:15 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
9
Price at Filing: $1.07
Real-time Price: $0.780 info
Change: -$0.290 (-27%) info
Market Cap: $2.649M info
PRFX
Sep 09, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.945
Real-time Price: $0.780 info
Change: -$0.165 (-17%) info
Market Cap: $2.649M info